Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Oncolytics Biotech Inc

NASDAQ: ONCY · Life Sciences · 10 alerts · CIK 1129928

Share price
$0.3399Close, Nov 16
Market cap
$46.3M
Shares outstanding
136.14MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Oncolytics Biotech Inc filings on SEC EDGAR ↗

4:17 PM ET 10-Q
Financial Results

Oncolytics Biotech Q3 2026 Results: Net Loss of $9.71M, Loss Narrows

Oncolytics Biotech Inc. reported a net loss of $28.4 million for the nine months ended September 30, 2026, compared to $19.9 million in the prior year period, driven by increased R&D and G&A expenses. The company's cash position decreased to $2.4 million, leading management to issue a going concern warning as existing resources are insufficient to fund operations for the next twelve months.

Key figure
Net loss $9.71M

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.